Rivelsa Kit
Product Images NDC 0093-6031

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rivelsa (NDC 0093-6031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

This looks like a chart or table showing percentages of bleeding and/or spotting during different cycles (Cycle 1, Cycle 2, Cycle 3, Cycle 4) over different time periods (Days 1-91, Days 92-182, Days 183-273, Days 274-364). The percentages range from 0% to 80%.*

FDA Label Image

Image 10

This is a not-available response as the text provided contains errors and is not readable.*

FDA Label Image

Image 2

FDA Label Image

Image 3

FDA Label Image

Image 4

FDA Label Image

Image 5

This appears to be a chart or table displaying different methods of birth control and their effectiveness rates. The methods listed include implants, intrauterine devices (IUDs), sterilization, birth control pills, skin patch, vaginal rings with hormones, condoms, and diaphragms. It also lists less reliable methods such as natural family planning (tracking monthly cycles), spermicide, and withdrawal. The chart emphasizes that using no birth control at all is the least effective method, while the most effective methods include implants, IUDs, and sterilization.*

FDA Label Image

Image 6

FDA Label Image

Image 7

FDA Label Image

Image 8

FDA Label Image

Image 9

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.